Investigation Overview
After the trading for shares of Jiangbo Pharmaceuticals, Inc. (NASDAQ:JGBO) was halted an investigation on behalf of investors of Jiangbo Pharmaceuticals (JGBO) over potential violations of Federal Securities Laws by Jiangbo Pharmaceuticals, Inc. was announced. The investigation by a law firm focuses on potential securities claims against Jiangbo Pharmaceuticals, Inc resulting from a...
You must register (for free) or login to view the entire investigation.